Eli Lilly & Co.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $40.99B | $46.63B | $3.66B |
| FY2021 | $39.83B | $48.81B | $3.82B |
| FY2022 | $38.84B | $49.49B | $2.07B |
| FY2023 | $53.23B | $64.01B | $2.82B |
| FY2024 | $64.44B | $78.72B | $3.27B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $40.99B | $46.63B | $3.66B |
| FY2021 | $39.83B | $48.81B | $3.82B |
| FY2022 | $38.84B | $49.49B | $2.07B |
| FY2023 | $53.23B | $64.01B | $2.82B |
| FY2024 | $64.44B | $78.72B | $3.27B |